185 related articles for article (PubMed ID: 4707544)
1. Androgens in breast cancer. I. Atypical endometrial hyperplasia and breast cancer in married premenopausal women.
Grattarola R
Am J Obstet Gynecol; 1973 Jun; 116(3):423-8. PubMed ID: 4707544
[TBL] [Abstract][Full Text] [Related]
2. Anovulation and increased androgenic activity as breast cancer risk in women with fibrocystic disease of the breast.
Gratterola R
Cancer Res; 1978 Sep; 38(9):3051-4. PubMed ID: 679211
[TBL] [Abstract][Full Text] [Related]
3. Androgens in breast cancer. III. Breast cancer recurrences years after mastectomy and increased androgenic activity.
Grattarola R; Secreto G; Recchione C
Am J Obstet Gynecol; 1975 Jan; 121(2):169-72. PubMed ID: 1115123
[TBL] [Abstract][Full Text] [Related]
4. The prevention of breast cancer through reduced ovarian steroid exposure.
Spicer DV; Pike MC
Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
[TBL] [Abstract][Full Text] [Related]
5. Testosterone and 17 beta-oestradiol secretion of the human ovary. I. normal young women, and premenopausal women with endometrial hyperplasia.
Botella-Llusiá J; Oriol-Bosch A; Sánchez-Garrido F; Tresguerres JA
Maturitas; 1980 Jan; 2(1):1-5. PubMed ID: 7402082
[TBL] [Abstract][Full Text] [Related]
6. Oestrogens and endometrial hyperplasia.
Thom MH; Studd JW
Br J Hosp Med; 1980 May; 23(5):506, 508-9, 511-3. PubMed ID: 6992895
[TBL] [Abstract][Full Text] [Related]
7. Aromatase in the context of breast and endometrial cancer. A review.
Jongen VH; Hollema H; Van Der Zee AG; Heineman MJ
Minerva Endocrinol; 2006 Mar; 31(1):47-60. PubMed ID: 16498363
[TBL] [Abstract][Full Text] [Related]
8. Behavior of some steroids in endometrial adenomatous and atypical hyperplasia.
Pelusi G; Moretti B; Martinelli G; Camerini T; Busacchi P; Cavallina R
Eur J Gynaecol Oncol; 1983; 4(2):131-4. PubMed ID: 6223817
[TBL] [Abstract][Full Text] [Related]
9. Role of estrogens and progesterone in the etiology and prevention of endometrial cancer: review.
Gambrell RD; Bagnell CA; Greenblatt RB
Am J Obstet Gynecol; 1983 Jul; 146(6):696-707. PubMed ID: 6307050
[TBL] [Abstract][Full Text] [Related]
10. The polycystic ovary. VII. Intractable uterine bleeding and endometrial hyperplasia possibly related to an extraovarian source of oestrogen.
Goldzieher JW; Fariss B
Acta Endocrinol (Copenh); 1967 Mar; 54(3):452-66. PubMed ID: 6071363
[No Abstract] [Full Text] [Related]
11. All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause.
Labrie F
J Steroid Biochem Mol Biol; 2015 Jan; 145():133-8. PubMed ID: 24923731
[TBL] [Abstract][Full Text] [Related]
12. [Hormonal correlations between cancer of the breast and atypical hyperplasia of the endometrium in premenopausal women].
Pozzi V
Minerva Ginecol; 1979; 31(7-8):569-74. PubMed ID: 481815
[TBL] [Abstract][Full Text] [Related]
13. Comparison of uterine, endometrial and ovarian blood flow by transvaginal color Doppler ultrasound in ovulatory and anovulatory cycles.
Dogan O; Yildiz A; Temizkan O; Pulatoglu C
Ginekol Pol; 2016; 87(8):581-4. PubMed ID: 27629133
[TBL] [Abstract][Full Text] [Related]
14. Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.
Katkam RR; Gopalkrishnan K; Chwalisz K; Schillinger E; Puri CP
Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):779-87. PubMed ID: 7573244
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of risk factors for hyperplasia and cancer of the endometrium.
Baanders-van Halewyn EA; Blankenstein MA; Thijssen JH; de Ridder CM; de Waard F
Eur J Cancer Prev; 1996 Apr; 5(2):105-12. PubMed ID: 8736077
[TBL] [Abstract][Full Text] [Related]
16. Endometrium in PCOS: Implantation and predisposition to endocrine CA.
Giudice LC
Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):235-44. PubMed ID: 16772154
[TBL] [Abstract][Full Text] [Related]
17. [Origin, variations and physiological role of steroid hormones during the menstrual cycle].
Bercovici JP
Nouv Presse Med; 1973 Jan; 2(2):103-9. PubMed ID: 4685762
[TBL] [Abstract][Full Text] [Related]
18. Interrelationship between excessive levels of circulating androgens in blood and ovulatory failure.
Parker CR; Mahesh VB
J Reprod Med; 1976 Aug; 17(2):75-90. PubMed ID: 134158
[TBL] [Abstract][Full Text] [Related]
19. High testosterone and low progesterone circulating levels in premenopausal patients with hyperplasia and cancer of the breast.
Secreto G; Recchione C; Fariselli G; Di Pietro S
Cancer Res; 1984 Feb; 44(2):841-4. PubMed ID: 6537901
[TBL] [Abstract][Full Text] [Related]
20. Long-term clinical outcomes following resectoscopic endometrial ablation of non-atypical endometrial hyperplasia in women with abnormal uterine bleeding.
Vilos GA; Oraif A; Vilos AG; Ettler H; Edris F; Abu-Rafea B
J Minim Invasive Gynecol; 2015 Jan; 22(1):66-77. PubMed ID: 25048567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
